Literature DB >> 30799628

Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Evan A Elko1, Brian Cunniff1, David J Seward1, Shi Biao Chia1, Reem Aboushousha1, Cheryl van de Wetering1, Jos van der Velden1, Allison Manuel1, Arti Shukla1, Nicholas H Heintz1, Vikas Anathy1, Albert van der Vliet1, Yvonne M W Janssen-Heininger1.   

Abstract

Significance: The lung is a unique organ, as it is constantly exposed to air, and thus it requires a robust antioxidant defense system to prevent the potential damage from exposure to an array of environmental insults, including oxidants. The peroxiredoxin (PRDX) family plays an important role in scavenging peroxides and is critical to the cellular antioxidant defense system. Recent Advances: Exciting discoveries have been made to highlight the key features of PRDXs that regulate the redox tone. PRDXs do not act in isolation as they require the thioredoxin/thioredoxin reductase/NADPH, sulfiredoxin (SRXN1) redox system, and in some cases glutaredoxin/glutathione, for their reduction. Furthermore, the chaperone function of PRDXs, controlled by the oxidation state, demonstrates the versatility in redox regulation and control of cellular biology exerted by this class of proteins. Critical Issues: Despite the long-known observations that redox perturbations accompany a number of pulmonary diseases, surprisingly little is known about the role of PRDXs in the etiology of these diseases. In this perspective, we review the studies that have been conducted thus far to address the roles of PRDXs in lung disease, or experimental models used to study these diseases. Intriguing findings, such as the secretion of PRDXs and the formation of autoantibodies, raise a number of questions about the pathways that regulate secretion, redox status, and immune response to PRDXs. Future Directions: Further understanding of the mechanisms by which individual PRDXs control lung inflammation, injury, repair, chronic remodeling, and cancer, and the importance of PRDX oxidation state, configuration, and client proteins that govern these processes is needed.

Entities:  

Keywords:  acute lung injury; cancer; fibrosis; malignant mesothelioma; peroxiredoxin; redox signaling

Mesh:

Substances:

Year:  2019        PMID: 30799628      PMCID: PMC6767868          DOI: 10.1089/ars.2019.7752

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  195 in total

1.  Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis.

Authors:  A Morinaka; Y Funato; K Uesugi; H Miki
Journal:  Oncogene       Date:  2011-04-25       Impact factor: 9.867

Review 2.  Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators.

Authors:  Ho Zoon Chae; Hammou Oubrahim; Ji Won Park; Sue Goo Rhee; P Boon Chock
Journal:  Antioxid Redox Signal       Date:  2012-03-15       Impact factor: 8.401

3.  Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.

Authors:  T Mitsudomi; J Viallet; J L Mulshine; R I Linnoila; J D Minna; A F Gazdar
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

4.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; S L North; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis.

Authors:  Vikas Anathy; Elle Roberson; Brian Cunniff; James D Nolin; Sidra Hoffman; Page Spiess; Amy S Guala; Karolyn G Lahue; Dylan Goldman; Stevenson Flemer; Albert van der Vliet; Nicholas H Heintz; Ralph C Budd; Kenneth D Tew; Yvonne M W Janssen-Heininger
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

6.  Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.

Authors:  Witold Mazur; Pamela Lindholm; Kirsi Vuorinen; Marjukka Myllärniemi; Kaisa Salmenkivi; Vuokko L Kinnula
Journal:  APMIS       Date:  2010-09-01       Impact factor: 3.205

7.  Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function.

Authors:  Ho Hee Jang; Kyun Oh Lee; Yong Hun Chi; Bae Gyo Jung; Soo Kwon Park; Jin Ho Park; Jung Ro Lee; Seung Sik Lee; Jeong Chan Moon; Jeong Won Yun; Yeon Ok Choi; Woe Yeon Kim; Ji Seoun Kang; Gang-Won Cheong; Dae-Jin Yun; Sue Goo Rhee; Moo Je Cho; Sang Yeol Lee
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

8.  An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib.

Authors:  Taeho Kwon; Jin Kyung Rho; Jae Cheol Lee; Young-Ho Park; Hye-Jun Shin; Sunwha Cho; Yong-Kook Kang; Bo-Yeon Kim; Do-Young Yoon; Dae-Yeul Yu
Journal:  Exp Mol Med       Date:  2015-05-29       Impact factor: 8.718

9.  The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.

Authors:  Akihiro Shioya; Xin Guo; Nozomu Motono; Seiya Mizuguchi; Nozomu Kurose; Satoko Nakada; Akane Aikawa; Yoshitaka Ikeda; Hidetaka Uramoto; Sohsuke Yamada
Journal:  Int J Med Sci       Date:  2018-06-14       Impact factor: 3.738

10.  Direct cysteine sulfenylation drives activation of the Src kinase.

Authors:  David E Heppner; Christopher M Dustin; Chenyi Liao; Milena Hristova; Carmen Veith; Andrew C Little; Bethany A Ahlers; Sheryl L White; Bin Deng; Ying-Wai Lam; Jianing Li; Albert van der Vliet
Journal:  Nat Commun       Date:  2018-10-30       Impact factor: 14.919

View more
  7 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

2.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

Review 3.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

4.  Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Authors:  Zdravka Daneva; Victor E Laubach; Swapnil K Sonkusare
Journal:  Curr Opin Physiol       Date:  2019-05-09

Review 5.  Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.

Authors:  Javier Checa; Josep M Aran
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

Review 6.  Antioxidant Systems, lncRNAs, and Tunneling Nanotubes in Cell Death Rescue from Cigarette Smoke Exposure.

Authors:  Jose Lorenzo M Ferrer; Reynaldo L Garcia
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

7.  The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.

Authors:  Tetsuya Hanaka; Takashi Kido; Shingo Noguchi; Sohsuke Yamada; Hirotsugu Noguchi; Xin Guo; Aya Nawata; Ke-Yong Wang; Keishi Oda; Tsutomu Takaki; Hiroto Izumi; Hiroshi Ishimoto; Kazuhiro Yatera; Hiroshi Mukae
Journal:  BMC Pulm Med       Date:  2019-12-30       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.